What Are Operating Costs For Oropharyngeal Airway Device Supply?
Oropharyngeal Airway Device Supply
Oropharyngeal Airway Device Supply Running Costs
Running an Oropharyngeal Airway Device Supply business requires careful management of high fixed overhead and complex variable costs In 2026, expect average monthly fixed operating costs-including salaries and rent-to be around $85,000 Your primary financial lever is managing the Cost of Goods Sold (COGS), which includes 246% of revenue allocated to production overhead like Quality Control, plus an additional 85% for sales commissions and distribution Given the projected $5325 million in Year 1 revenue, you must maintain tight control over per-unit costs to sustain the 14811% Internal Rate of Return (IRR) You hit break-even in January 2026, but cash management remains critical, especially with the $1149 million minimum cash requirement
7 Operational Expenses to Run Oropharyngeal Airway Device Supply
#
Operating Expense
Expense Category
Description
Min Monthly Amount
Max Monthly Amount
1
Fixed Payroll
Personnel
Fixed salaries for 5 FTEs (including CEO and Regulatory Director) total $51,667 monthly, requiring careful staffing decisions before product-market fit is defintely proven.
$51,667
$51,667
2
Facility Lease
Real Estate
Headquarters rent ($12,000/month) plus R&D Lab Utilities ($1,500/month) establish a base facility cost of $13,500.
$13,500
$13,500
3
Regulatory & QMS
Compliance
Maintaining FDA compliance requires $2,500 monthly for Quality Management System (QMS) software subscriptions.
$2,500
$2,500
4
Insurance/Liability
Risk Management
General Liability insurance is a fixed $3,800 monthly, separate from variable product insurance and liability reserves.
$3,800
$3,800
5
Sales & Freight
Variable COGS/Sales
Variable costs for sales commissions (50%) and distribution/freight (35%) total 85% of revenue, impacting contribution margin.
$0
$0
6
Marketing & IP
SG&A
Fixed marketing spend for trade shows ($8,500/month) and ongoing legal/patent maintenance ($5,000/month) represent $13,500 in spending.
$13,500
$13,500
7
Indirect Overhead
Production Overhead
Indirect production overhead, including Clean Room Maintenance, Facility Lease Allocation, and Supervisory Labor, totals 246% of your gross revenue.
$0
$0
Total
All Operating Expenses
$84,967
$84,967
Oropharyngeal Airway Device Supply Financial Model
5-Year Financial Projections
100% Editable
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Accounting Or Financial Knowledge
What is the total monthly running budget required to maintain operations before direct materials?
Before buying materials for the Oropharyngeal Airway Device Supply, you need about $85,000 monthly to cover fixed operating costs, a number critical when planning your How To Write Oropharyngeal Airway Device Supply Business Plan? This figure represents the average total fixed overhead-salaries, rent, software, and insurance-required to keep the lights on through 2026.
Fixed Cost Components
Salaries are the largest portion of this spend.
Facility costs include monthly rent payments.
Essential software subscriptions are factored in.
Annual insurance premiums are amortized monthly.
Budget Context
This estimate is the 2026 projected average.
It excludes all direct materials purchases.
This is your baseline monthly burn rate.
Review this defintely before scaling initial sales.
Which cost categories represent the largest recurring monthly expenditures?
The largest recurring monthly costs for the Oropharyngeal Airway Device Supply business are fixed payroll and production overhead, which is critical context when analyzing How Increase Oropharyngeal Airway Device Supply Profitability? Fixed payroll clocks in at $517k monthly, while production overhead consumes a massive 246% of total revenue.
Fixed Payroll Burden
Fixed payroll hits $517,000 monthly, regardless of sales volume.
This cost structure demands high sales velocity just to cover staffing expenses.
The current team size must support 100% of projected peak demand capacity.
Review staffing efficiency against the $1.2M annual R&D budget allocation.
Overhead Eats Revenue
Production overhead stands at a massive 246% of gross revenue.
This means for every dollar earned, you spend $2.46 on production support infrastructure.
Material costs are accounted for separately, but this overhead is defintely unsustainable long-term.
Scaling unit volume is the only way to dilute this high fixed overhead base effectively.
How much working capital buffer is necessary to cover operating expenses during sales cycles?
For the Oropharyngeal Airway Device Supply business, securing the $1149 million minimum cash requirement projected for January 2026 is more critical than covering immediate operating expenses, as break-even happens fast. Honestly, while you might hit operational profitability quickly, that massive future cash requirement dictates your entire funding strategy right now; you can read more about the initial setup here: How Do I Launch Oropharyngeal Airway Device Supply Business? If onboarding new hospital systems takes longer than expected, that buffer gets eaten faster than you think.
Immediate vs. Future Cash Focus
Break-even point arrives quickly in theory.
Focus shifts fast to scaling inventory needs.
Working capital must bridge the gap to January 2026.
Hospital procurement cycles demand long cash coverage.
If actual revenue falls 20% below forecast, which fixed costs can be quickly reduced or deferred?
If actual revenue for the Oropharyngeal Airway Device Supply business falls 20% below forecast, immediately cut non-essential fixed spending like Marketing and Trade Shows ($8,500/month) and Legal/Patent Maintenance ($5,000/month) before impacting quality teams; this swift action is crucial for immediate cash preservation, which you can explore further in How Increase Oropharyngeal Airway Device Supply Profitability?
Prioritize Spending Cuts
Protect staff tied to regulatory compliance.
Quality assurance personnel are defintely non-negotiable.
Defer non-critical capital expenditures now.
Hold off on hiring for non-revenue generating roles.
Identify Quick Savings
Marketing and trade shows total $8,500 monthly.
Legal and patent upkeep costs $5,000 monthly.
These discretionary areas offer fast relief.
Cutting these avoids touching core operations.
Oropharyngeal Airway Device Supply Business Plan
30+ Business Plan Pages
Investor/Bank Ready
Pre-Written Business Plan
Customizable in Minutes
Immediate Access
Key Takeaways
The baseline monthly fixed overhead for running the Oropharyngeal Airway Device Supply business averages $85,000, demanding significant scaling to absorb these costs.
Profitability hinges on aggressively controlling variable expenditures, which collectively amount to 331% of revenue across production overhead and sales commissions.
Fixed payroll expenses for core staff, amounting to $51,667 monthly, constitute the largest single component of the recurring fixed operating costs.
Although the business model projects immediate break-even in January 2026, securing the required $1.149 million minimum cash reserve remains critical for managing working capital.
Running Cost 1
: Fixed Payroll and Benefits
Staffing Burn Rate
Your fixed payroll commitment hits $51,667 monthly by 2026 for just 5 key people, including the CEO and Regulatory Director. This high baseline cost demands aggressive revenue generation or lean staffing until market acceptance is certain.
Payroll Inputs
This $51,667 monthly figure covers salaries and benefits for 5 essential roles projected for 2026. Since you need a Regulatory Director early, expect high initial overhead tied to medical device compliance. You need a clear hiring roadmap tied to sales milestones, not just projections.
5 FTEs locked in for 2026
Includes CEO and Regulatory Director
Monthly cost: $51,667
Controlling Fixed Pay
Hiring 5 people upfront creates a steep fixed cost floor you must cover monthly, regardless of unit sales. Avoid hiring non-essential roles until you secure major hospital or EMS contracts. If onboarding takes 14+ days, churn risk rises, but hiring too fast is worse.
Delay non-critical hires
Use consultants for specialized tasks
Keep headcount lean until revenue is certain
Staffing Risk
That $51,667 monthly payroll is a massive fixed drain when you're still proving market fit for your oropharyngeal airway devices. You need to know exactly how many units you must sell just to cover this payroll before you sign those employment contracts, defintely.
Running Cost 2
: Facility Lease and Utilities
Base Facility Burn
Your base facility expenses, covering headquarters rent and R&D utilities, total $13,500 monthly before any production space costs are allocated. This fixed burn rate hits your runway immediately, so you need to know this number exactly when planning startup capital.
Facility Cost Breakdown
This initial spend covers the $12,000 headquarters rent and $1,500 for R&D lab utilities. Since you're pre-revenue, this is pure fixed overhead impacting your cash position. You must track the specific lease start date to time this expense against funding milestones. What this estimate hides is the utility allocation for actual manufacturing space.
HQ Rent: $12,000/month
R&D Utilities: $1,500/month
Total Base Cost: $13,500
Managing Fixed Space Costs
Avoid signing long-term HQ leases before you secure FDA clearance for your oral airway devices. Co-working spaces or smaller serviced offices can replace the $12,000 rent initially, saving cash. Remember, R&D utilities are fixed, but production utilities are tied to usage, so keep the lab footprint tight. Don't confuse this base cost with the much larger production overhead.
Delay HQ commitment
Use flexible office space
Keep R&D footprint small
Accounting for Overhead
Clearly segmenting the $13,500 G&A/R&D facility cost from the variable production utility allocation (which is part of the 246% indirect overhead) lets you calculate true gross margin accurately. This separation is defintely critical for investors assessing unit economics.
Running Cost 3
: Regulatory Compliance and QMS
Compliance Cost Structure
FDA compliance mandates a fixed baseline cost plus a revenue-linked penalty for documentation. You must budget $2,500 monthly for Quality Management System (QMS) software subscriptions. On top of that, expect variable costs of 12% of revenue to cover all required reporting and documentation as sales ramp up.
QMS Cost Breakdown
The $2,500 covers the essential software platform needed to manage quality records. The 12% variable component scales with your sales volume, covering costs like generating Device History Records or handling field reports. If you hit $200k in revenue, that variable compliance spend alone is $24,000 that month.
Fixed cost: $2,500/month subscription
Variable cost: 12% of total revenue
Inputs: Revenue figures, documentation volume
Managing Compliance Spend
You can't skimp on FDA compliance, but you can control the variable spend defintely early on. Focus on automating data entry within the QMS platform to cut down on the manual labor hours that drive up that 12% variable cost. Don't over-engineer documentation for processes that aren't yet scaled.
Automate data entry where possible
Audit software features yearly
Standardize all reporting templates
Compliance as Margin Test
This $2,500 plus 12% of revenue is a non-negotiable operating cost for this market. If your contribution margin after direct costs doesn't comfortably absorb these regulatory overheads, your unit economics won't support sustainable growth in the US medical device sector.
Running Cost 4
: Insurance and Liability Reserve
Insurance Cost Structure
Insurance costs combine a fixed $3,800 monthly premium with variable exposure linked directly to sales volume. You must account for 0.7% of revenue dedicated to product insurance and setting aside a liability reserve to protect your balance sheet.
Calculating Exposure Costs
General Liability insurance is a non-negotiable fixed cost of $3,800 per month, covering general operational risks for your medical device supply business. Beyond that, you need variable coverage: 0.4% of revenue for product insurance and a mandatory 0.3% of revenue set aside monthly for product liability reserves.
Fixed GL: $3,800/month.
Variable Insurance: Revenue × 0.004.
Reserve Allocation: Revenue × 0.003.
Managing Liability Spend
Since the reserve is tied to revenue, managing sales volume volatility helps stabilize this line item. For fixed General Liability, shop quotes yearly; bundling policies might save you money, but don't compromise coverage for medical devices. The biggest lever is accurate revenue forecasting to avoid surprise shortfalls in the reserve account.
Shop GL quotes yearly.
Forecast revenue accurately.
Keep reserve separate from cash flow.
Total Annual Insurance Burden
The total insurance burden is $3,800 fixed plus 0.7% of gross revenue. If your projected Year 1 revenue hits $4 million, this line item costs you $28,000 annually, separate from the $45,600 fixed GL premium. Honesty about this risk exposure is key to sustainable growth.
Running Cost 5
: Sales Commissions and Freight
Variable Cost Squeeze
Your sales commissions and freight costs swallow up most of your top line. With 50% for sales commissions and 35% for moving the devices, these two variable costs consume 85% of revenue before you even cover overhead. This leaves a razor-thin margin to cover everything else.
Cost Calculation Inputs
Estimate these costs by multiplying expected revenue by the known percentages. Sales commissions cover the cost of securing the sale, likely paid to distributors or internal reps. Freight is the cost to ship the specialized medical devices to hospitals and EMS providers. You need solid pricing agreements to nail these inputs.
Sales commission rate: 50%
Freight rate: 35%
Total variable drain: 85%
Managing High Variable Costs
Because these costs scale directly with sales, reducing them is critical for profitability. Focus on negotiating better freight rates by consolidating shipments to major regional hubs, like shipping to a central EMS depot instead of many small fire stations. Also, review commission structures to ensure they reward efficient, high-margin sales. It's a tough nut to crack.
Margin Reality Check
That 85% combined cost structure means your contribution margin is only 15% before accounting for fixed costs like payroll and regulatory fees. If your unit economics don't support this high variable load, you'll need massive volume just to cover the $51,667 monthly salaries and $13,500 facility rent, which is defintely achievable with volume.
Running Cost 6
: Marketing and IP Maintenance
Fixed Marketing & IP
You have $13,500 per month locked into non-revenue-generating fixed costs for marketing and intellectual property protection. This discretionary spend requires immediate scrutiny against your cash runway, especially since it sits alongside high payroll and facility overhead costs. Honestly, this is a big chunk of non-operational burn.
Cost Components
This $13,500 monthly commitment covers two distinct areas critical for a medical device company selling to hospitals and EMS. Trade shows cost $8,500, aiming to drive leads, while the remaining $5,000 covers ongoing legal fees to maintain your patents and regulatory standing. These are inputs you must fund before sales start coming in.
Trade shows: $8,500 monthly.
Legal/Patent upkeep: $5,000 monthly.
Total fixed overhead: $13,500.
Managing Outbound Spend
Since these costs are fixed, reducing them means cutting market exposure or pausing protection, which carries inherent risk for a specialized supplier. For marketing, analyze the actual lead-to-sale conversion from trade shows versus cheaper digital outreach, aiming to cut two shows per quarter if cash is tight. Legal costs are harder to trim but confirm you aren't overpaying for routine filing management.
Pause non-essential trade shows now.
Negotiate annual patent renewal schedules.
Target 15% reduction in external legal retainer.
Fixed Cost Pressure
This $13,500 marketing and IP bucket adds significant pressure to your operating budget. When compared to your $51,667 payroll and $13,500 facility lease, you are already burning over $78,667 monthly before accounting for variable costs like commissions or overhead allocations. Cash management here is key.
Running Cost 7
: Indirect Production Overhead
Overhead Shock
Your indirect production overhead is currently calculated at 246% of gross revenue. This ratio, driven by maintenance, lease allocation, and labor, means every dollar earned is immediately offset by nearly three dollars in overhead before direct costs hit. This structure is not viable for scaling a medical device supplier.
Overhead Breakdown
This massive overhead figure includes specific allocations: 15% for Clean Room Maintenance, 15% for Facility Lease Allocation, and 14% for Supervisory Labor. To estimate this cost monthly, you multiply projected revenue by 2.46. What this estimate hides is that these are fixed-like costs tied to capacity, not volume.
Clean Room Maintenance: 15% of revenue
Facility Lease Allocation: 15% of revenue
Supervisory Labor: 14% of revenue
Cutting Overhead
You can't reduce a percentage of revenue unless you change the underlying fixed costs or dramatically increase sales volume. Since these are tied to facility requirements, look at outsourcing non-core functions or renegotiating the lease structure immediately. If facility usage is low, subleasing excess lab space is defintely an option.
Renegotiate facility lease terms now.
Explore shared clean room access.
Audit supervisory labor efficiency.
The Ratio Problem
A 246% overhead ratio means you need 3.46x revenue just to cover these indirect production costs before accounting for direct costs like sales commissions (85%) or fixed payroll ($51,667 monthly). You must decouple facility costs from revenue projection immediately.
Fixed operating costs, including $51,667 in salaries and $33,300 in fixed overhead, total about $85,000 monthly, before variable COGS and distribution Total costs fluctuate based on sales volume, but the fixed base is substantial
The largest fixed cost is personnel ($51,667/month), but the largest variable cost category is indirect production overhead, which consumes 246% of gross revenue, followed by sales commissions at 50%
The financial model projects an immediate break-even in January 2026 (1 month), indicating strong initial margins and pre-funding of significant capital expenditures like the $210,000 Sterilization Chamber Setup
The direct COGS for a Standard OPA Device is approximately $130 per unit, covering materials like Medical Grade Polymer ($045), Injection Molding Labor ($035), and Sterile Packaging ($025) This is critical since the unit sale price starts at $1250 in 2026
Initial capital expenditures (CapEx) are high, totaling $580,000 for items like Injection Molding Dies ($120,000), R&D Lab Equipment ($85,000), and the Sterilization Chamber Setup ($210,000)
Revenue is projected to grow from $5325 million in Year 1 to $22790 million by Year 5, representing a compound annual growth rate (CAGR) of roughly 442%, driven by scaling unit volume from 320,000 to 142 million units
About the author
Oscar Bryant
Startup Planning Writer
Oscar Bryant is a startup planning writer at Financial Models Lab, where he helps early-stage founders make a business idea easier to evaluate through simple financial projections. He breaks down revenue, expenses, and profit in a clear, practical way, with a focus on cost and income assumptions that help readers understand the numbers behind everyday business ideas.
Choosing a selection results in a full page refresh.
